Current use of pre-clinical models for evaluation of human adenovirus-based cancer therapeutics
{{output}}
Human adenoviruses (HAdVs) are enjoying a renaissance in interest for the development of cancer therapies following the approval of Adstiladrin (Ferring Pharmaceuticals) for the treatment of bladder cancer, strong phase 3 data from CG Oncology's cretostimogen... ...
